Subtotal gastrectomy for diffused hemorrhagic gastritis induced by radiation, following liver resection for hilar cholangiocarcinoma. A case report  by Tatsis, Vasileios et al.
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INTRODUCTION:  A rare  case of  hemorrhagic  gastritis  induced  by  radiation  is presented,  which  was  resis-
tant  to conservative  treatment  and  required  subtotal  gastrectomy.
PRESENTATION  OF  CASE:  A 56-year-old  male  was  initially  undergone  right  hepatectomy,  resection  of  the
extrahepatic  biliary  tree,  hilar  lymph  node  dissection  and  hepatico-jejunostomy  due  to  advanced  hilar
cholangiocarcinoma.  Because  of the extent  of  the  disease,  chemo-radiotherapy  was  administered.  The
patient  received  a total  radiotherapy  dose  of  57.6 Gy  in 32  sessions.  Unfortunately,  diffused  hemorrhagiceywords:
emorrhagic gastritis induced by radiation
urgical treatment
astrectomy
gastritis  induced  by radiation  was  developed,  which was  resistant  to conservative  treatment  (endoscopic
hemostasis,  transfusion).  A subtotal  gastrectomy  was  performed.  The  patient  is  in  good  condition  45
months  after  the liver  resection,  but with  local  recurrence.
CONCLUSION:  In resistant  situations  to conservative  treatment  and recurred  bleeding  of  diffused  hemor-
y  rad
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. Introduction
Radiotherapy is used often for the management of malignant
umors. However its use is not without consequences. Hemorrhagic
astritis induced by radiation is a potential life-threatening compli-
ation and the management is challenging. There is no treatment of
hoice so far. We  present a patient who developed severe persistent
pper gastrointestinal bleeding three months after radiotherapy
or resected advanced hilar cholangiocarcinoma. This complication
as effectively managed with subtotal gastrectomy and Roux-en-
 gastro-jejunostomy.
. Methods
This work has been reported in line with the CARE Guidelines
1].. Case report
A 56-year-old male with hilar cholangiocarcinoma (stage IIIA)
as submitted to right hepatectomy, excision of the extrahep-
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reativecommons.org/licenses/by-nc-nd/4.0/).iation,  surgical  management  may  have  a  role.
shed  by  Elsevier  Ltd.  on behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
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atic biliary tree, hilar lymph node dissection and Roux-en-ϒ
hepatico-jejunostomy in our department, in 09/2011. Histological
examination showed hilar cholangiocarcinoma with max  diame-
ter 3.5 cm and perineural inﬁltration (R0 resection, without lymph
node invasion).
The patient was  submitted to chemo-radiotherapy postoper-
atively due to tumor extension. He received chemotherapy of
oxaliplatin and capecitabine (3 cycles). He also underwent 32 ses-
sions of radiotherapy (started on 12/2011, duration: 1.5 months)
using external beam radiation of the right hypochondrium and
epigastrium. The radiotherapy was held in four ﬁelds radiation
(anterior–posterior, right–left) using linear accelerator (18 MV).
The patient received a total dosage of 57.6 Gy.  The daily dosage
was 1.8 Gy using shrinkage technique. The whole stomach received
a mean dosage of 18.2 Gy (range from 0.3 Gy to 61.5 Gy). The dis-
tal part of the stomach received from 0.6 Gy minimum to 61.5 Gy
maximum, with a mean dosage of 53 Gy.
Unfortunately, the patient developed upper gastrointestinal
bleeding (hematemesis and melena) three months after the
completion of radiotherapy. Initially, he was treated at his
district hospital using proton pump inhibitors. Esophagogastro-
duodenoscopy (EGD) showed diffused hemorrhagic lesions in
multiple sites in the gastric mucosa (Fig. 1). He was  managed
there with transfusion of red blood cells (RBCs) and fresh frozen
plasma (FFPs), but the bleeding recurred. He was referred to our
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Esophagogastroduodenoscopy: diffuse vascular lesions in multiple site
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There is one case report which shows patient’s susceptibilityig. 2. Surgical specimen of subtotal gastrectomy where ﬁndings of diffused hem-
rrhagic gastritis can be seen.
ospital, where another effort of conservative treatment of upper
astrointestinal bleeding was attempted with several sessions of
ndoscopic hemostasis (cautery, injection of adrenalin) and trans-
usion of RBCs and FFPs, but with no success. He totally received
4 units of RBCs and 20 units of FFPs at both hospitals, in 36
ays. Unfortunately the bleeding persisted. For this reason surgical
anagement was decided. A subtotal gastrectomy with Roux-en-
 gastro-jejunostomy was performed. Histology showed diffused
emorrhagic gastritis induced by radiation (Fig. 2). The postoper-
tive period was uneventful and the patient was discharged on
he 17th postoperative day. He developed a mild myelodysplas-
ic syndrome after radiation; however he had a very good quality
f life. Unfortunately, 45 months after the hepatectomy, he devel-
ped local recurrence in the liver which is going to be managed
ith radio-frequency ablation.
. Discussion
Upper gastrointestinal bleeding, due to diffused hemorrhagic
astritis induced by radiation is very rare. Only two cases required
urgical management are reported in the literature. In the ﬁrst case
 total gastrectomy was performed due to post-radiotherapy hem-
rrhagic gastritis in a patient with primary gastric non-Hodgkin’s
ymphoma [2]. In the second case a 66-year-old male with
arcinoma of the hypopharynx, underwent pharyngo-laryngo-
sophagectomy, using the stomach as a replacement conduit.
e developed hematemesis and tarry stools 5 months after the
ompletion of radiotherapy. Conservative management was not
uccessful. For this reason he underwent a subtotal gastrectomys of the gastric mucosa, consistent with diffused hemorrhagic gastritis.
and a portion of jejunum was  placed between pharynx and the
remaining stomach, as a conduit [3].
Acute vasculopathy at the irradiated stomach may progress to
obliterative endarteritis, vasculitis and endothelial proliferation,
which leads to mucosal ischemia, telangiectasias and ulceration.
The mucosa of irradiated stomach seems friable with multiple
telangectasias leading to a chronic radiation injury causing bleed-
ing [4,5]. The stomach has a thick muscular and mucosal layer and is
relatively resistant to radiation. It is likely that the ulceration of the
irradiated stomach is caused due to the destruction of the mucosal
cells of the gastric mucosa. The prime change is edema, which
appears immediately after irradiation. Disruption of the epithelial
cells of the mucosa and the stromal cells appears about in 1 week.
This is primarily hyperemia, hemorrhage and inﬁltration with leu-
cocytes. These changes can lead to ulceration from 1 to 3 months [6].
The injury of the stomach varies from mucosal inﬂammation, caus-
ing dyspepsia-nausea-vomiting, to bleeding and ulceration. The
majority of symptoms occur within 3 years after the completion
of radiotherapy. Patients who were cured from a complication of
irradiated stomach are also at risk for future complications [7].
Most of the knowledge about the tolerance radiation dose on
the stomach is from clinical studies of radiotherapy in the treat-
ment of Hodgkin’s disease [3,6]. In this case the lymph nodes of the
upper abdomen are irradiated, however the stomach is also irra-
diated unintentionally. These studies proved that the big fraction
and the great total dose of radiotherapy are related to a higher rate
of late radiation complications [3]. Emami  et al. suggest that the
TD5/5 of the stomach was  60 Gy, 55 Gy, and 50 Gy when one-third,
two-thirds and the entire stomach was  irradiated, respectively (for
ulceration–perforation) [8]. Very few reports demonstrate ulcera-
tion under 45 Gy. Other factors that may  contribute to the stomach
toxicity induced by radiation are previous abdominal surgery and
cirrhosis [6,7]. Yet, the reason for such a serious bleeding compli-
cation in our patient is uncertain, as both the total dose of radiation
and fraction size are within the recommended ranges. The total
dose is within Emami’s recommended TD5/5 (53 Gy  for one third
of the stomach irradiated) and the low fraction of 1.8 Gy.
Although, there are several reports with increased incidence
of hemorrhagic gastritis after radiation therapy combined with
chemotherapy, the inﬂuence of chemotherapy on the toxicity of
the irradiated stomach is uncertain. The chemotherapy agents that
have been reported in such cases are 5-ﬂuorouracil, gemcitabine,
mitomycin-C, lomustine (CCNU), paclitaxel and carboplatin, which
have been used alone or in combination. In these studies the
chemotherapy was given after the completion of radiotherapy or
concurrently [4–7,9–11]to radiotherapy. That patient who  was operated for esophageal
adenocarcinoma was  postoperatively administered chemotherapy
and radiotherapy. Three months after the end of radiotherapy, he
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as presented to the emergency department with melena and
ow hematocrit. Gastroscopy showed diffuse hemorrhagic gastri-
is presumably secondary to radiation effect. Five months after this
pisode he was diagnosed with non-metastatic stage V prostate
ancer. For this reason, pelvic radiotherapy was applied and a few
eeks later he complained about melena and he had low hemat-
crit. Taking this case into consideration, we can assume that some
eople are more susceptible to radiation than others. However
ore evidence is required in order to reach solid conclusions [5].
In most cases the treatment of the upper gastrointestinal bleed-
ng is conservative by endoscopic therapy and blood transfusion.
ther treatment methods that have been reported for diffused,
emorrhagic gastritis due to radiation are endoscopic band liga-
ion [4], epsilon-aminocaproic acid (EACA) [5], hyperbaric oxygen
reatment [9], radiofrequency ablation and argon plasma coagula-
ion. [10,11] Recent papers have reported the successful use of oral
dministered prednisolone for intractable bleeding from hemor-
hagic gastritis induced by radiation [12,13].
In our case, endoscopic treatment with cautery and adrenaline
njection had been attempted several times but failed to control the
leeding. Surgical treatment was necessary because of the failure
f conservative treatment and massive requirements in transfu-
ion of RBCs and FFPs in 36 days of hospitalization. Despite the fact
hat most cases of upper gastrointestinal bleeding can be managed
owadays conservatively, taking into consideration the favorable
utcome in our case, we can conclude that surgical management of
ntractable bleeding for hemorrhagic gastritis induced by radiation
ay  has a role in the armamentarium for the management of this
are and difﬁcult to manage life threatening condition.
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